Physician
Carlson, David
Carlson, David was paid $1.04M by Medicaid between Sep 2018 and Feb 2022, across 10 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 76% of everything it billed.
33Billing provider infoCARLSON, DAVID
BILLINGS, MT 59101
BILLINGS, MT 59101
33aNPI1891804589assigned 08/29/2006
33bProvider typePsychiatry Physician
28Total paid$1.04M
24GClaims35,015
24DCodes billed10
24AFirst – last monthSep 2018 – Feb 2022
Compared with peers
Next to other Psychiatry Physician providers in Montana
Rank by total paid#6 of 13
Median peer was paid$808K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 951 | $2K | |
| 2019 | 12,987 | $342K | |
| 2020 | 9,000 | $283K | |
| 2021 | 11,031 | $371K | |
| 2022 | 1,046 | $38K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 76% | 26,775 | 7,095 | $785K |
| 82075 | 9.0% | 5,249 | 3,041 | $94K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 582 | 343 | $67K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.2% | 607 | 558 | $44K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.4% | 606 | 557 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 680 | 609 | $10K |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | <1% | 78 | 68 | $10K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 28 | 28 | $7K |
| 86580 | <1% | 374 | 361 | $4K | |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 0% | 36 | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.